SARS-CoV-2 antibodies and proteins

The newly identified coronavirus, SARS-CoV-2 (previously known as 2019-nCoV) shares 79.5% sequence identify with SARS-CoV. The viral genome encodes spike, envelope, membrane, nucleocapsid, and multiple non-structural proteins. arigo offers quality antibodies and proteins to facilitate the research of SARS-CoV-2.

SARS-CoV-2 cell entry depends on viral spike protein and ACE2 which mediates conversion of Angiotensin II to Angiotensin 1-7. The receptor-binding domain (RBD) of the spike protein is essential for ACE2 binding. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach for COVID-19 treatment.

● Spike antibodies & proteins

● ELISA kits for ACE2 research

ACE2 shedding
Human ACE2 ELISA Kit
(ARG80959)
Sensitivity: 31 pg/ml
Sample: Serum, plasma, cell culture supernatant

ACE2 deficiency
Human Angiotensin II ELISA Kit
(ARG80961)
Sensitivity: 2 pg/ml
Sample: Serum, plasma, cell culture supernatant, homogenate

ACE2 deficiency
Human Angiotensin 1-7 ELISA Kit
(ARG80960)
Sensitivity: 2 pg/ml
Sample: Serum, plasma, cell culture supernatant

● ACE2 and TMPRSS2 antibodies

The nucleocapsid protein is a structural protein required for genomic RNA packaging. It is the most abundant protein in coronavirus and often used as a marker in diagnostic assays.

● M and NS proteins ●

● More Coronavirus reagents ●

Read More
ACE2, receptor of SARS-CoV-2
New Recombinant Human anti-SARS-CoV-2 Antibody is released

Download
Flyer of Coronaviruses products
Poster of SARS-CoV & SARS-CoV-2